Screener
R&D at other companies
Other financials
Where this comes from
Reported directly by Edgewell Personal Care in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The source filing: Edgewell Personal Care’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 1:38 PM EDT
- Fiscal quarter
- Q3 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053128
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Nine Months Ended June 30, 2026 | Nine Months Ended June 30, 2025 |
|---|---|---|---|---|
| Gross profit | 242.5 | 250.1 | 620.4 | 659.4 |
| Selling, general and administrative expense | 108.3 | 100.7 | 321.7 | 303.1 |
| Advertising and sales promotion expense | 83.2 | 76.0 | 187.4 | 182.0 |
| Research and development expense | 13.3 | 13.5 | 42.0 | 40.2 |
| Restructuring charges | 12.7 | 14.9 | 44.8 | 30.9 |
| Operating income | 25.0 | 45.0 | 24.5 | 103.2 |
| Interest expense associated with debt | 16.7 | 19.4 | 53.9 | 58.4 |
| Other income, net | (9.7) | (2.9) | (18.4) | (2.3) |
Item 1. Financial Statements.
FAQ
- What is Edgewell Personal Care's R&D?
- Edgewell Personal Care (EPC) reported R&D of $13.3M in Q2 2026.
- How has Edgewell Personal Care's R&D changed year-over-year?
- Edgewell Personal Care's R&D decreased by 1.5% year-over-year, from $13.5M to $13.3M.
- What is the long-term trend for Edgewell Personal Care's R&D?
- Over 4 years (2021 to 2025), Edgewell Personal Care's R&D has grown at a -0.0% compound annual growth rate (CAGR), from $57.8M to $57.7M.
- What does R&D mean?
- Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.
Ask your AI about Edgewell Personal Care's r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude